C018 Updates in Hair Disorders
DESCRIPTION
A wide spectrum of scalp disorders will be covered including alopecia areata, androgenetic hair loss, acute and chronic telogen effluvium and cicatricial alopecia, including lichen planopilaris and frontal fibrosing alopecia. Alopecias in cancer patients and survivors will be discussed. The efficacy of the latest state of the art treatments such as JAK inhibitors, topical and intralesional anti-androgens will be evaluated. Trichoscopy and scalp pathology in distinguishing scalp disorders will be emphasized. An update on surgical techniques in hair transplantation will be presented. Ethnic hair disorders such as central centrifugal cicatricial alopecia in terms of recognition and treatment will be covered.
LEARNING OBJECTIVES
Diagnose and manage cicatricial alopecias, alopecia areata, and androgenetic hair loss.
Distinguish scalp disorders by trichoscopy and scalp pathology.
Recognize ethnic hair disorders.
SCHEDULE
1:00 PM
Lichen Planopilaris Update: What I do
Jerry Shapiro, MD, FAAD
1:15 PM
JAK inhibitors for alopecia areata: maintenance, downtitration, safety and what is the fastest way to get your chosen JAK inhibitor to your alopecia areata patient
Brett Andrew King, MD, PhD, FAAD
1:30 PM
Hair Surgery Update
Sergio Vano-Galvan, MD, PhD, IFAAD
1:45 PM
Dermoscopy Update in the evaluation and treatment of hair loss
Lidia Rudnicka, MD, PhD, IFAAD
2:00 PM
The long and winding road of minoxidil in the evaluation and treatment of hair loss
Elise A. Olsen, MD, FAAD
2:15 PM
The Hair Cycle Rules
George Cotsarelis, MD, FAAD
2:30 PM
Central Centrifugal Cicatricial Alopecia: Latest Data
Pearl E. Grimes, MD, FAAD
2:45 PM
Hair Loss in Women: My approach for general hair loss in women.
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
3:00 PM
Aiding the dermatopathologist to deliver a more accurate meaningful report
Mariya Miteva, MD
3:15 PM
Frontal Fibrosing Alopecia: My Approach
Rodrigo Pirmez, MD
3:30 PM
Mesotherapy for Androgenetic Alopecia
3:45 PM
Alopecia in cancer patients and survivors
Azael David Freites Martinez, MD, IFAAD
DIRECTOR
Jerry Shapiro, MD, FAAD
SPEAKERS
George Cotsarelis, MD, FAAD
Azael David Freites Martinez, MD, IFAAD
Pearl E. Grimes, MD, FAAD
Brett Andrew King, MD, PhD, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Mariya Miteva, MD
Elise A. Olsen, MD, FAAD
Rodrigo Pirmez, MD
Lidia Rudnicka, MD, PhD, IFAAD
Sergio Vano-Galvan, MD, PhD, IFAAD
HANDOUTS
DISCLOSURES
George Cotsarelis, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Almirall – Investigator(Grants/Research Funding); Follica – Advisory Board(Honoraria), Founder(Stock Options); GlaxoSmithKline – Speaker(Honoraria); JW Pharmaceutical Corp – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding);
Azael David Freites Martinez, MD, IFAAD
I.F.C., S.A. – Speaker(Honoraria); ISDIN – Speaker/Faculty Education(Honoraria); Janssen Pharmaceuticals, Inc – Speaker/Faculty Education(Fees); L'Oréal France – Investigator(Fees); sanofi-aventis – Consultant(Fees);
Pearl E. Grimes, MD, FAAD
AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Mariya Miteva, MD
Absci – Advisory Board(Honoraria); Cassiopea, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Informa – Other(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Elise A. Olsen, MD, FAAD
Absci – Advisory Board(Honoraria); Aranda Pharm Ltd – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cosmos – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Taisho Pharmaceuticals Co., Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Lidia Rudnicka, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); DS Laboratories – Consultant (1099 relationship)(Honoraria); Eirion Therapeutics – Consultant (1099 relationship)(Stock Options); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Fees), Stockholder Public Company(No Compensation Received);
Sergio Vano-Galvan, MD, PhD, IFAAD
AbbVie – Speaker(Fees); Cantabria Labs – Advisory Board(Fees); Fotofinder – Speaker(Fees); L'Oréal France – Advisory Board(Fees); Lilly ICOS LLC – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Fees);